Your browser doesn't support javascript.
loading
First pass effect as an independent predictor of functional outcomes in medium vessel occlusions: An analysis of an international multicenter study.
Radu, Razvan Alexandru; Costalat, Vincent; Fahed, Robert; Ghozy, Sherief; Siegler, James E; Shaikh, Hamza; Khalife, Jane; Abdalkader, Mohamad; Klein, Piers; Nguyen, Thanh N; Heit, Jeremy J; Sweid, Ahmad; El Naamani, Kareem; Regenhardt, Robert W; Diestro, Jose Danilo Bengzon; Cancelliere, Nicole M; Amllay, Abdelaziz; Meyer, Lukas; Dusart, Anne; Bellante, Flavio; Forestier, Géraud; Rouchaud, Aymeric; Saleme, Suzana; Mounayer, Charbel; Fiehler, Jens; Kühn, Anna Luisa; Puri, Ajit S; Dyzmann, Christian; Kan, Peter T; Colasurdo, Marco; Marnat, Gaultier; Berge, Jérôme; Barreau, Xavier; Sibon, Igor; Nedelcu, Simona; Henninger, Nils; Kyheng, Maéva; Marotta, Thomas R; Stapleton, Christopher J; Rabinov, James D; Ota, Takahiro; Dofuku, Shogo; Yeo, Leonard Ll; Tan, Benjamin Yq; Martinez-Gutierrez, Juan Carlos; Salazar-Marioni, Sergio; Sheth, Sunil; Renieri, Leonardo; Capirossi, Carolina; Mowla, Ashkan.
Afiliación
  • Radu RA; Department of Neuroradiology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
  • Costalat V; Department of Neuroradiology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
  • Fahed R; Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, ON, Canada.
  • Ghozy S; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Siegler JE; Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowan University, Camden, NJ, USA.
  • Shaikh H; Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowan University, Camden, NJ, USA.
  • Khalife J; Cooper Neurological Institute, Cooper University Hospital, Cooper Medical School of Rowan University, Camden, NJ, USA.
  • Abdalkader M; Departments of Radiology & Neurology, Boston Medical Center, Boston, MA, USA.
  • Klein P; Departments of Radiology & Neurology, Boston Medical Center, Boston, MA, USA.
  • Nguyen TN; Departments of Radiology & Neurology, Boston Medical Center, Boston, MA, USA.
  • Heit JJ; Department of Interventional Neuroradiology, Stanford Medical Center, Palo Alto, CA, USA.
  • Sweid A; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • El Naamani K; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Regenhardt RW; Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Diestro JDB; Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada.
  • Cancelliere NM; Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada.
  • Amllay A; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Meyer L; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Dusart A; Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium.
  • Bellante F; Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium.
  • Forestier G; University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.
  • Rouchaud A; University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.
  • Saleme S; University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.
  • Mounayer C; University Hospital of Limoges, Neuroradiology Department, Dupuytren, Université de Limoges, XLIM CNRS, UMR 7252, Limoges, France.
  • Fiehler J; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kühn AL; Department of Radiology, University of Massachusetts Memorial Hospital, Worcester, MA, USA.
  • Puri AS; Department of Radiology, University of Massachusetts Memorial Hospital, Worcester, MA, USA.
  • Dyzmann C; Department of Diagnostic and Interventional Radiology and Neuroradiology, Sana Klinik Lübeck, Lübeck, Germany.
  • Kan PT; Department of Neurosurgery, University of Texas Medical Branch, Galveston, Texas, USA.
  • Colasurdo M; Department of Neurosurgery, University of Texas Medical Branch, Galveston, Texas, USA.
  • Marnat G; Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.
  • Berge J; Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.
  • Barreau X; Interventional Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France.
  • Sibon I; Neurology Department, Bordeaux University Hospital, Bordeaux, France.
  • Nedelcu S; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Henninger N; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Kyheng M; Department of Psychiatry, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Marotta TR; Department of Biostatistics, CHU Lille, Lille, France.
  • Stapleton CJ; Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada.
  • Rabinov JD; Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Ota T; Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Dofuku S; Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
  • Yeo LL; Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
  • Tan BY; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Martinez-Gutierrez JC; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Salazar-Marioni S; Division of Neurology, Department of Medicine, National University Hospital, Singapore.
  • Sheth S; Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.
  • Renieri L; Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.
  • Capirossi C; Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.
  • Mowla A; Interventistica Neurovascolare, Ospedale Careggi di Firenze, Florence, Italy.
Eur Stroke J ; 9(1): 114-123, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37885243
INTRODUCTION: First pass effect (FPE), achievement of complete recanalization (mTICI 2c/3) with a single pass, is a significant predictor of favorable outcomes for endovascular treatment (EVT) in large vessel occlusion stroke (LVO). However, data concerning the impact on functional outcomes and predictors of FPE in medium vessel occlusions (MeVO) are scarce. PATIENTS AND METHODS: We conducted an international retrospective study on MeVO cases. Multivariable logistic modeling was used to establish independent predictors of FPE. Clinical and safety outcomes were compared between the two study groups (FPE vs non-FPE) using logistic regression models. Good outcome was defined as modified Rankin Scale 0-2 at 3 months. RESULTS: Eight hundred thirty-six patients with a final mTICI ⩾ 2b were included in this analysis. FPE was observed in 302 patients (36.1%). In multivariable analysis, hypertension (aOR 1.55, 95% CI 1.10-2.20) and lower baseline NIHSS score (aOR 0.95, 95% CI 0.93-0.97) were independently associated with an FPE. Good outcomes were more common in the FPE versus non-FPE group (72.8% vs 52.8%), and FPE was independently associated with favorable outcome (aOR 2.20, 95% CI 1.59-3.05). 90-day mortality and intracranial hemorrhage (ICH) were significantly lower in the FPE group, 0.43 (95% CI, 0.25-0.72) and 0.55 (95% CI, 0.39-0.77), respectively. CONCLUSION: Over 2/3 of patients with MeVOs and FPE in our cohort had a favorable outcome at 90 days. FPE is independently associated with favorable outcomes, it may reduce the risk of any intracranial hemorrhage, and 3-month mortality.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular Límite: Humans Idioma: En Revista: Eur Stroke J Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Isquemia Encefálica / Accidente Cerebrovascular Límite: Humans Idioma: En Revista: Eur Stroke J Año: 2024 Tipo del documento: Article País de afiliación: Francia